CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock [Member] Class A Common Stock [Member]	Common Stock [Member] Class B Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2022	$ 12	$ 2	$ 758,366		$ (399,674)	$ 358,706
Balance (in shares) at Dec. 31, 2022	120,006,757	19,937,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon vesting of restricted stock units	$ 0	$ 0	0		0	0
Common stock issued upon vesting of restricted stock units (in shares)	1,552,583	0
Stock-based compensation	$ 0	$ 0	3,908		0	3,908
Net unrealized loss on marketable securities, net of tax						0
Foreign currency translation						0
Net loss	0	0	0		(23,611)	(23,611)
Balance at Mar. 31, 2023	$ 12	$ 2	762,274		(423,285)	339,003
Balance (in shares) at Mar. 31, 2023	121,559,340	19,937,500
Balance at Dec. 31, 2023	$ 12	$ 2	767,239	$ 0	(495,634)	271,619
Balance (in shares) at Dec. 31, 2023	121,832,417	19,937,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon vesting of restricted stock units	$ 0	$ 0	0	0	0	0
Common stock issued upon vesting of restricted stock units (in shares)	46,572	0
Stock-based compensation	$ 0	$ 0	1,645	0	0	1,645
Net unrealized loss on marketable securities, net of tax	0	0	0	(28)	0	(28)
Refund of issuance costs from 2021 Business Combination	0	0	14	0	0	14
Foreign currency translation	0	0	0	(5)	0	(5)
Net loss	0	0	0	0	(19,474)	(19,474)
Balance at Mar. 31, 2024	$ 12	$ 2	$ 768,898	$ (33)	$ (515,108)	$ 253,771
Balance (in shares) at Mar. 31, 2024	121,878,989	19,937,500